Nov. 22, 2004 — The U.S. Food and Drug Administration (FDA) and Pfizer have notified healthcare professionals via letter of revisions to the safety labeling for medroxyprogesterone acetate (MPA) ...

A new study in The American Journal of Pathology, published by Elsevier, reports that medroxyprogesterone acetate (MPA), the active ingredient in the common contraceptive injection Depo-Provera, was ...

WESTWEGO, Louisiana — Robin Phillip’s fresh haircut is dyed her favorite color — green. But beneath the dye job is a scar that runs along the side of her head, the result of two craniotomies. For ...

Feb. 2, 2005 — The U.S. Food and Drug Administration (FDA) approved revisions to drug safety labeling last November, advising healthcare professionals of the following changes: use of ...

The South African Health Products Regulatory Authority (Sahpra) says products with medroxyprogesterone acetate (MPA) are viewed as safe. It has, however, recommended that the product information of ...

A new study in The American Journal of Pathology reports that medroxyprogesterone acetate (MPA), the active ingredient in the common contraceptive injection Depo-Provera, was effective in preventing ...

Postmenopausal Bleeding Case with Medroxyprogesterone Acetate Therapy Ms. R, a 62-year-old G0 woman presents to the office requesting a refill of her prescription of medroxyprogesterone acetate (MPA; ...

The birth control shot Depo Provera offers a convenient alternative for women who don't want to remember to take a daily pill. Ironically, research from Arizona State University has shown the shot ...

A breakthrough study conducted by Professor Keertan Dheda and Dr Michele Tomasicchio, at the University of Cape Town’s (UCT) Centre for Lung Infection and Immunity, has revealed that one of South ...

Findings reported in The American Journal of Pathology suggest medroxyprogesterone acetate as a new affordable non-invasive approach to combat cervical cancer, particularly for women with limited ...